Experimental Ebola Vaccine Trial Begins in Congo

An experimental Ebola vaccine has entered its first human clinical trial in Congo, marking a significant step in the ongoing effort to combat the deadly viral disease in the region.

The trial follows reports of international diplomatic efforts, including U.S. President Donald Trump's recent comments regarding potential deals with Iran, though the primary focus remains on regional health security.

Researchers are monitoring the initial phase of the study to evaluate the safety and efficacy of the vaccine candidate among the local population participating in the trial.